Rare diseases
Investigational molecules
Locations
Study of Pembrolizumab and MK-2870 for Patients with Metastatic Squamous Non-small Cell Lung Cancer
AustriaStudy on Reducing Chemotherapy Cycles with Pembrolizumab for Patients with PD-L1-Positive Recurrent or Metastatic Head and Neck Cancer
FranceStudy of Ifinatamab Deruxtecan with Atezolizumab and Carboplatin for Patients with Extensive-Stage Small Cell Lung Cancer
FranceStudy on Retinoblastoma Treatment Using Etoposide, Carboplatin, and Melphalan for Patients with Specific Eye Conditions
FranceStudy on Breast Cancer Treatment with Carboplatin for Patients in Neoadjuvant and Metastatic Stages
NorwayStudy on the Effects of Adding Durvalumab After Chemotherapy and Surgery in Patients with Resectable Non-Small Cell Lung Cancer
AustriaStudy of Pembrolizumab, Vibostolimab, and Chemotherapy for Patients with Newly Diagnosed Resectable Stage II-IIIB Non-Small Cell Lung Cancer
GreeceStudy on Medulloblastoma Treatment in Children Aged 3-5 Using Carboplatin and Drug Combination
AustriaStudy of Volrustomig and Drug Combination for Patients with Early-stage Resectable Non-small Cell Lung Cancer
BelgiumStudy of Cemiplimab, Carboplatin, and Paclitaxel for Adults with Operable Non-Small Cell Lung Cancer
FranceStudy on Pembrolizumab and Chemotherapy with Radiation for Advanced Non-Small Cell Lung Cancer Patients
FranceStudy of Carboplatin, Paclitaxel, and Cetuximab for Patients with Recurrent or Metastatic Head and Neck Cancer After Pembrolizumab Treatment Failure
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
